The Pharmaceutical Society NI Podcast
The Pharmaceutical Society NI Podcast
Podcast Description
The official podcast of the Pharmaceutical Society NI. Hosted on Acast. See acast.com/privacy for more information.
Podcast Insights
Content Themes
Focuses on the evolution of the pharmaceutical profession, including education, training, and industry innovations with episodes covering historical insights from seasoned pharmacists and advice for new entrants into the field.
The official podcast of the Pharmaceutical Society NI.
Hosted on Acast. See acast.com/privacy for more information.
Professor Mike Mawhinney completed a Pharmacy degree and a Doctorate in Pharmaceutics through The Queen’s University School of Pharmacy, and later went on to complete a LL.M in Medical Law.
Having enjoyed a number of key roles within the wider pharmacy arena – including Central Services Agency, Regional Renal Unit and Clinical Fellow NI Kidney Research Fund – he was central to the establishment of, and was the first to head up, the Department of Health’s Medicines Regulatory Group (MRG).
Since 2018 he has been Head of Regulatory Affairs at Community Pharmacy NI.
Mike sat down with his old friend and colleague, our CEO Canice Ward, to discuss his varied career, and in particular the amazing and inspiring pharmacists he has met and worked with along the way.
For more about the Pharmaceutical Society NI go to www.psni.org.uk and please follow us on the below social media accounts:
Hosted on Acast. See acast.com/privacy for more information.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.